Integrative CRISPR-Cas9 dependency analysis identifies CDC45 as a candidate prognostic biomarker with preliminary functional validation in prostate adenocarcinoma
This study provides a dependency-informed prognostic framework for PRAD and nominates CDC45 as a candidate prognostic biomarker, laying the groundwork for future mechanistically resolved investigations.